Skip to main content
Signal8

Sanitam Partners LLC

SEC insider (Form 3/4/5 filer). CIK 0002056830. 10% Owner at Matinas BioPharma Holdings, Inc. (MTNB). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in NEW YORK, NY.

Companies Sanitam Partners LLC has filed insider reports for

  • Matinas BioPharma Holdings, Inc. (MTNB): 10% Owner
Sanitam Partners LLC profile photo

Sanitam Partners LLC

CIK: 0002056830

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Matinas BioPharma Holdings, Inc. logo
MTNB

Matinas BioPharma Holdings, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Jun 10, 2026
    Other

    Series C Convertible Preferred Stock

    Direct
    1.4K shares at avg. $0.59-
  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Jun 10, 2026
    Other

    Warrants to Purchase Common Stock

    Direct
    4.8M shares at avg. $0.64-
  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Apr 8, 2025
    Purchase

    Series C Convertible Preferred Stock

    Direct
    703 shares at avg. $1000.00-
  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Apr 8, 2025
    Purchase

    Warrants

    Direct
    2.4M shares-

1-4 of 4